USPTO 2015–2025 USPTO PatentsView US Corporation

Cardiac Pacemakers, Inc.

USPTO PatentsView assignee record - 1,178 granted patents across 81 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

1,178

Total patents granted

CPC technology areas

17.9

Avg claims per patent

-37%

5-year filing velocity

The verdict

Cardiac holds 1,178 US patents across 81 technology areas, rank #369 of 50,000 tracked assignees.

#369
of 50,000 US assignees by volume: Top 2%
by Innovation Score (64.0/100): 17.9
avg claims per patent: -37%
filing velocity, last 5 yrs

Portfolio overview

Cardiac Pacemakers, Inc. has been granted 1,178 US utility patents between 2015 and 2025, placing Cardiac Pacemakers, Inc. at rank #369 across all assignees tracked by PlainPatent. This portfolio spans 81 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Cardiac Pacemakers, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Cardiac sits between Cummins Inc. (1,191 patents, rank #365) and Quanta Computer Inc. (1,171 patents, rank #373) - the closest US assignees by grant volume. The composite Innovation Score of 64.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 457 grants, compared with 721 in the 2015–2019 window, a -37% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cardiac Pacemakers, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 81 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cardiac Pacemakers, Inc. against peers pursuing similar technology classes.

Cummins

1,191
HRL Laboratories

1,188
UOP

1,188
Vestas Wind Syste…

1,179
Cardiac Pacemakers ◀

1,178
Karsten Manufactu…

1,177
Kla-tencor

1,173
Smith & Nephew

1,172
Quanta Computer

1,171

What this shows Cardiac holds 1,178 patents at rank #369, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardiac

By rank, the assignees closest to #369 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cardiac's primary technology class.

Cardiac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cardiac Pacemakers, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	193	16.4%
2016	159	13.5%
2017	153	13.0%
2018	90	7.6%
2019	126	10.7%
2020	121	10.3%
2021	109	9.3%
2022	99	8.4%
2023	63	5.3%
2024	42	3.6%
2025	23	2.0%

Which technologies does Cardiac Pacemakers, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1,037

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 609

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 165

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 73

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 67

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 37

H01R - ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS 37

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 26

H01M - PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY 23

H01G - CAPACITORS; CAPACITORS, RECTIFIERS, DETECTORS, SWITCHING DEVICES, LIGHT-SENSITIVE OR TEMPERATURE-SENSITIVE DEVICES OF THE ELECTROLYTIC TYPE 22

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 21

G16Z - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR 19

H05K - PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS 17

H04B - TRANSMISSION 16

H01Q - ANTENNAS, i.e. RADIO AERIALS 15

Top 15 of 81 technology areas

Patent Moat Analysis

Portfolio Volume Strong

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#369

Across all tracked assignees

Innovation Score

64.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cardiac Pacemakers, Inc. hold?

Cardiac Pacemakers, Inc. holds 1,178 US granted patents filed between 2015 and 2025, spanning 81 technology areas.

What is Cardiac Pacemakers, Inc.'s Innovation Score?

Cardiac Pacemakers, Inc. has an Innovation Score of 64.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cardiac Pacemakers, Inc. focus on?

Cardiac Pacemakers, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 1,037 patents. The company has filed patents in 81 CPC subclasses total.

Is Cardiac Pacemakers, Inc.'s patent filing rate increasing or decreasing?

Cardiac Pacemakers, Inc.'s recent filing velocity is -37% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Cardiac Pacemakers, Inc.'s patents?

Cardiac Pacemakers, Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Cardiac Pacemakers, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cardiac's 1,178 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cardiac ranks #369 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.